Enable Injections said last week that it closed a $50 million Series B round, led by Sanofi (NYSE:SNY), to fund the development of its enFuse on-body drug-delivery system.
Previous investors, including the Cleveland Clinic and CincyTech, and private investors also participated in the round.
Get the full story at our sister site, Drug Delivery Business News.
The post Sanofi leads $50m round for Enable Injections’ on-body drug-delivery platform appeared first on MassDevice.